Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Genetic drugs: percentage of patents worldwide 2010

Distribution of patents for genetically engineered drugs by country in 1990, 2008 and 2010 (in percent)

by Statista Research Department, last edited Dec 10, 2011
Genetic drugs: percentage of patents worldwide 2010 This statistic illustrates the distribution of patents for genetic drugs by country in 1990, 2008 and 2010. In 1990, some 45 percent of all patents for genetically engineered drugs worldwide came from the United States.
Show more

Distribution of patents for genetically engineered drugs by country in 1990, 2008 and 2010 (in percent)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.